final 1 Flashcards

1
Q

It uses computer simulations to predict the behavior of molecules and their interactions.

A

Molecular modeling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

It virtually tests millions of compounds against target molecules, identifying potential drug candidates for further research and development.

A

In silico screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

It automates the testing of large libraries of compounds against a specific target.

A

High Throughput Screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

It enables researchers to rapidly screen thousands or millions of compounds, identifying potential drug candidates.

A

High Throughput Screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

HTS helps identify “___,” compounds that show promising activity against the target, paving the way for further investigation.

A

hits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

It systematically generates and screens
large libraries of chemical compounds.

It involves systematically combining different building blocks to create diverse molecules.

A

Combinatorial chemistry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

These libraries are then screened against biological targets to identify potential drug candidates, enabling the exploration of a vast chemical space.

A

Compound Libraries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

It provides crucial insights into the three-
dimensional structures of proteins, their interactions with other molecules, and their functional roles in biological processes.

A

Structural biology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

These strategies focus on designing drugs that bind to specific protein sites, modulating their activity and potentially inhibiting disease progression.

A

Protein targeting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

These are used to understand how fragments bind.

A

X-ray crystallography and NMR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Leads with improved properties are further optimized to become drug
candidates.

A

Fragment-Based Drug Discovery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

In Fragment-Based Drug Discovery, Fragments are modified and combined to improve:

A

binding affinity and potency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Starts with small molecules, “fragments”, that bind to a target protein.

A

Fragment-Based Drug Discovery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

It allows simultaneous analysis of multiple cellular parameters in a single experiment, providing a comprehensive
view of drug effects.

A

High-Content Screening (HCS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

This approach enhances data quality and accelerates the identification of promising drug candidates.

A

High-Content Screening (HCS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

They mimic the complex environment of living tissues, providing a more accurate
representation of drug responses.

A

Three-dimensional cell culture models

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

These models improve prediction of drug efficacy and reduce the need for animal testing.

A

Three-dimensional cell culture models

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

It studies the entire genome, including genes, mutations, and variations. This provides insights into genetic predispositions to diseases and potential drug targets.

A

Genomics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

It focuses on proteins, analyzing their structure, function, and interactions. It helps identify biomarkers and understand how drugs affect protein pathways.

A

Proteomics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Combining __ and ___ offers a more comprehensive understanding of disease mechanisms. It enables the development of personalized therapies based on individual genetic profiles and protein expression patterns.

A

genomics

proteomics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

AI can analyze vast datasets to identify potential drug targets, speeding up the discovery process.

A

Target Identification (Artificial Intelligence and Machine Learning)

22
Q

These can rapidly screen millions of molecules to identify promising drug candidates.

A

AI algorithms

23
Q

They can predict drug efficacy, safety, and pharmacokinetic properties, reducing the risk of failure in later stages.

24
Q

AI can optimize ___, making them more
efficient and cost-effective

A

clinical trial designs

25
It is a crucial aspect of drug discovery.
ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) modeling
26
They utilize computational approaches to estimate a drug candidate's pharmacokinetic and pharmacodynamic properties.
Predictive ADMET models
27
How well a drug is absorbed into the bloodstream
Absorption
28
How a drug spreads throughout the body.
Distribution
29
How a drug is broken down in the body.
Metabolism
30
How a drug is removed from the body.
Excretion
31
The potential harmful effects of a drug.
Toxicity
32
These are tiny chips that mimic the human body's organ functions.
Microfluidic devices
33
These platforms enable researchers to study drug effects and responses in a controlled environment.
Microfluidic Devices
34
These are a powerful tool for drug discovery and development. They provide a more physiologically relevant model than traditional cell cultures.
Organ-on-a-chip systems
35
These models improve predictions of drug efficacy and toxicity in human trials.
Organ-on-a-chip systems
36
It utilizes genetic, genomic, and other data to create customized treatment plans. This approach considers individual differences in genes, lifestyle, and environment, allowing for more targeted and effective therapies.
Personalized medicine
37
These tests help identify patients most likely to benefit from a specific treatment, predicting drug response and potential adverse effects.
Companion Diagnostics
38
This emerging field focuses on developing targeted therapies and diagnostics for specific patient populations, improving treatment outcomes and reducing unnecessary side effects.
Precision Medicine
39
These are biological indicators that can help predict disease risk, monitor disease progression, or evaluate the effectiveness of treatments.
Biomarkers
40
In clinical trials, it allows for personalized medicine approaches, tailoring treatments to individual patients based on their unique biological characteristics.
Biomarker validation
41
These can be used to develop accurate and sensitive diagnostic tests that enable early detection and intervention, improving patient outcomes.
Biomarkers
42
Allow for modifications to trial protocols based on accumulating data.
Adaptive Designs
43
Enrolls patients with different tumor types but similar genetic alterations.
Basket Trials
44
Test multiple drugs simultaneously against a single target.
Umbrella Trials
45
Evaluate various therapies for a specific disease or condition.
Platform Trials
46
Ethical Considerations and Patient
• Centricity • Informed Consent • Data Privacy • Equity and Access • Transparency and Communication
47
These are often stigmatized and undertreated, requiring innovative therapies and support systems.
Mental health disorders
48
It is a growing concern, leading to a need for novel antibiotics and antiviral therapies.
Antimicrobial resistance
49
Many rare diseases lack effective treatments. Drug development for these diseases is often challenging due to limited patient populations and high costs.
50
Prevalent in developing countries, it often lack adequate resources for research and development of new treatments.
Tropical diseases